Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-022156
Filing Date
2025-07-03
Accepted
2025-07-03 16:46:13
Documents
20
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A gnpx20250314_pre14a.htm   iXBRL PRE 14A 1289291
6 card01.jpg GRAPHIC 362243
7 card02.jpg GRAPHIC 285220
8 gen1.jpg GRAPHIC 7071
9 proxy_netloss2025800px.jpg GRAPHIC 72981
10 proxy_tsr2025800px.jpg GRAPHIC 74393
  Complete submission text file 0001437749-25-022156.txt   3704687

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20241231.xsd EX-101.SCH 4569
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20241231_pre.xml EX-101.PRE 714
22 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250314_pre14a_htm.xml XML 6194
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38244 | Film No.: 251106113
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)